Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

ERS Genomics/Aelian Biotechnology: CRISPR License Agreement (2020-02-11)
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology (“Aelian”) today announced the signing of a license agreement granting Aelian acces...
ERS Genomics: EPO Affirms Key CRISPR-Cas9 Patent (2020-02-10)
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced today that the European Patent Office (EPO) has rejected arguments filed in opposition to European pat...
Exscientia/Sumitomo Dainippon: AI-created Drug Enters Clinic (2020-01-30)
Sumitomo Dainippon Pharma Co., Ltd. (Head office: Osaka, Japan, Representative Director, President and CEO: Hiroshi Nomura) and Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) announce that a phase I clinical study of DSP-1181, that was created usin...
Quench Bio Closes $50m Series A Financing, Led by RA Capital (2020-01-27)
Experienced team focused on inhibiting inflammatory cell death underlying a range of severe inflammatory diseases Quench Bio, a company leveraging new insights into gasdermin biology and innate immunology to develop medicines for severe inflammatory diseases, ...
Santhera Appoints Andrew Smith as CFO; Joins from Allecra (2020-01-24)
Santhera Pharmaceuticals (SIX: SANN) announces the appointment of Andrew Smith as CFO and a member of the Executive Management team, effective April 1, 2020. Andrew Smith joins Santhera with broad experience in corporate and operational finance in the pharmac...
Ervaxx & Cardiff University to Develop TCR Cancer Therapies (2020-01-24)
Ervaxx™, a biotechnology company pioneering the use of Dark Antigens™ to develop T-cell receptor (TCR)-based immunotherapies and off-the-shelf cancer vaccines, has entered a licensing and research collaboration with a leading T-cell immunology group at Cardiff Univ...
iOnctura Raises €15m Series A Financing to Enter the Clinic (2020-01-23)
iOnctura B.V., a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, announces today the closing of a EUR 15 million Series A financing. The financing was led by INKEF Capital and co-led by VI ...
PureTech Health: $200m from Sale of Shares of Karuna Tx (2020-01-23)
PureTech Health plc (LSE: PRTC) (“PureTech” or the “Company”), a clinical stage biotechnology company dedicated to discovering, developing and commercialising highly differentiated medicines for devastating diseases, today announces that it has sold 2.1 million sha...
Oxford Investment Opportunity Network & Oxford Angel Network (2020-01-23)
Leading angel networks in Oxford merge to catalyse early-stage tech investment in the Oxford Cluster. Oxford Investment Opportunity Network (OION) and Oxford Angel Network (OAN), part of Oxford University’s commercialisation arm Oxford University Innovation (OUI...
Exscientia Appoints David Hallett as COO, Joins from Evotec (2020-01-21)
Exscientia, the leading AI drug discovery company, has appointed Dr. David Hallett as its Chief Operating Officer and Head of Drug Discovery. Dr. Hallett will be responsible for Exscientia’s full drug discovery portfolio, reporting into the CEO, Prof. Andrew Hopkin...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

Start here with the latest News!

Picture [iito] – Putting Information into Context 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top